减少美国医疗保险计划中废弃的来卡尼单抗的浪费支出。

IF 22.5 1区医学 Q1 MEDICINE, GENERAL & INTERNAL

JAMA Internal Medicine Pub Date : 2024-12-01 DOI:10.1001/jamainternmed.2024.5292

Frank F Zhou, Chi-Hong Tseng, Mei Leng, Benjo A Delarmente, Cheryl L Damberg, Catherine A Sarkisian, John N Mafi

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Reducing Wasteful Spending on Discarded Lecanemab in the US Medicare Program.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JAMA Internal Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

43.50

自引率

1.30%

发文量

371

期刊介绍： JAMA Internal Medicine is an international, peer-reviewed journal committed to advancing the field of internal medicine worldwide. With a focus on four core priorities—clinical relevance, clinical practice change, credibility, and effective communication—the journal aims to provide indispensable and trustworthy peer-reviewed evidence. Catering to academics, clinicians, educators, researchers, and trainees across the entire spectrum of internal medicine, including general internal medicine and subspecialties, JAMA Internal Medicine publishes innovative and clinically relevant research. The journal strives to deliver stimulating articles that educate and inform readers with the latest research findings, driving positive change in healthcare systems and patient care delivery. As a member of the JAMA Network, a consortium of peer-reviewed medical publications, JAMA Internal Medicine plays a pivotal role in shaping the discourse and advancing patient care in internal medicine.